Fig. 2From: Antithrombotic drug removal with hemoadsorption during off-pump coronary artery bypass graftingA: Hemoadsorption device (CytoSorb® 300, CytoSorbents Inc., Princeton, NJ, USA) incorporated in the apheresis machine (PuriFi by CytoSorbents CytoSorbents Europe GmbH, Germany); B: Schematic drawing of the extracorporeal circuit of the PuriFiBack to article page